![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 207/267 | |
A61K 31/197 | |||
A61K 31/4015 | |||
A61P 25/08 | |||
C07C 233/47 |
(11) | Number of the document | 3148969 |
(13) | Kind of document | T |
(96) | European patent application number | 15803860.4 |
Date of filing the European patent application | 2015-06-02 | |
(97) | Date of publication of the European application | 2017-04-05 |
(45) | Date of publication and mention of the grant of the patent | 2020-11-11 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/CA2015/050507 |
Date | 2015-06-02 |
(87) | Number | WO 2015/184542 |
Date | 2015-12-10 |
(30) | Number | Date | Country code |
201462006515 P | 2014-06-02 | US |
(72) |
ARAUJO, Joseph A., CA
ANDREWS, John S., CA
ANNEDI, Subhash C., CA
HIGGINS, Guy A., CA
MILGRAM, Norton W., CA
ESTEY, Paula J., CA
ROBINSON, Gary L. W. G., US
NAGIREDDY, Jaipal R., CA
|
(73) |
Ketogen Inc.,
120 Carlton Street Suite 204, Toronto, Ontario M5A 4K2,
CA
|
(54) | COMPOUNDS FOR THE TREATMENT OF SEIZURES AND OTHER CENTRAL NERVOUS SYSTEM DISORDERS AND CONDITIONS |
COMPOUNDS FOR THE TREATMENT OF SEIZURES AND OTHER CENTRAL NERVOUS SYSTEM DISORDERS AND CONDITIONS |